chr3-13504106-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_024827.4(HDAC11):​c.662G>A​(p.Arg221Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

HDAC11
NM_024827.4 missense

Scores

1
4
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.42
Variant links:
Genes affected
HDAC11 (HGNC:19086): (histone deacetylase 11) This gene encodes a class IV histone deacetylase. The encoded protein is localized to the nucleus and may be involved in regulating the expression of interleukin 10. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Apr 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06185007).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HDAC11NM_024827.4 linkuse as main transcriptc.662G>A p.Arg221Gln missense_variant 9/10 ENST00000295757.8 NP_079103.2 Q96DB2-1
HDAC11NM_001136041.3 linkuse as main transcriptc.509G>A p.Arg170Gln missense_variant 9/10 NP_001129513.1 Q96DB2-2
HDAC11NM_001330636.2 linkuse as main transcriptc.425G>A p.Arg142Gln missense_variant 6/7 NP_001317565.1 B5MCQ6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HDAC11ENST00000295757.8 linkuse as main transcriptc.662G>A p.Arg221Gln missense_variant 9/101 NM_024827.4 ENSP00000295757.3 Q96DB2-1

Frequencies

GnomAD3 genomes
AF:
0.000315
AC:
48
AN:
152198
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000108
AC:
27
AN:
250658
Hom.:
0
AF XY:
0.0000958
AC XY:
13
AN XY:
135680
show subpopulations
Gnomad AFR exome
AF:
0.000926
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000795
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.0000486
AC:
71
AN:
1461676
Hom.:
0
Cov.:
31
AF XY:
0.0000399
AC XY:
29
AN XY:
727116
show subpopulations
Gnomad4 AFR exome
AF:
0.00116
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000188
Gnomad4 NFE exome
AF:
0.0000207
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152316
Hom.:
0
Cov.:
33
AF XY:
0.000295
AC XY:
22
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00108
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000554
Hom.:
0
Bravo
AF:
0.000208
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000165
AC:
20

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 22, 2022The c.662G>A (p.R221Q) alteration is located in exon 9 (coding exon 9) of the HDAC11 gene. This alteration results from a G to A substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.072
D
BayesDel_noAF
Benign
-0.12
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.012
T;T;.;T
Eigen
Benign
0.073
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.61
.;T;T;T
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.062
T;T;T;T
MetaSVM
Benign
-0.68
T
PROVEAN
Benign
0.57
N;.;N;N
REVEL
Benign
0.13
Sift4G
Pathogenic
0.0
D;D;.;D
Polyphen
0.33
B;B;.;.
Vest4
0.55
MutPred
0.15
Gain of glycosylation at S182 (P = 0.0048);Gain of glycosylation at S182 (P = 0.0048);.;.;
MVP
0.64
ClinPred
0.17
T
GERP RS
4.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150690094; hg19: chr3-13545606; COSMIC: COSV99041495; COSMIC: COSV99041495; API